Susceptibility Of Copd And Cigarette Smoke Airway Epithelia To Sars-Cov-2

Grant number: unknown

Grant search

Key facts

  • Disease

    COVID-19
  • Funder

    Animal Free Research UK
  • Principal Investigator

    Dr. Baishakhi Ghosh
  • Research Location

    United Kingdom
  • Lead Research Institution

    Johns Hopkins Hospital
  • Research Priority Alignment

    N/A
  • Research Category

    Clinical characterisation and management

  • Research Subcategory

    Prognostic factors for disease severity

  • Special Interest Tags

    N/A

  • Study Type

    Unspecified

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Unspecified

  • Vulnerable Population

    Unspecified

  • Occupations of Interest

    Unspecified

Abstract

The lungs are the organs most affected by COVID-19 as the SARS-CoV-2 virus results in asymptomatic or mild symptoms hospitalizations and mortality due to respiratory failure. Given the enormous impact of the virus on health and well-being, it is important to get insight into its pathogenic interaction with humans. We are exploring the epithelial changes that lead to increased susceptibility to disease, and also, quantifying changes that occur after viral exposure to determine the likelihood of chronic respiratory disease even after recovery from acute infection. Our understanding of the role of environmental exposures such as cigarette-smoke or vaping electronic cigarettes in modifying the response to SARS-CoV-2 is emerging and smoking has been associated with worsened outcomes in SARS-CoV-2 patients. The proposed study will improve our understanding of how cigarette smoke increases our susceptibility to SARS-CoV-2 infection in the lungs and help in developing a therapy for prevention and treatment.